PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
October 15, 1988Annals of Internal Medicine36 citations

Hypertension, Exercise, and Beta-Adrenergic Blockade

View Full Paper
PAPhilip A. Ades

Structured PICO

Do beta-adrenergic blocking agents (propranolol or metoprolol) affect exercise tolerance, exercise conditioning response, and blood pressure response to conditioning in hypertensive patients?

P
Population
30 adults with hypertension (mean resting blood pressure ≥145 mm Hg systolic, ≥95 mm Hg diastolic, or combined ≥140/90 mm Hg; excluding mean systolic ≥170 mm Hg or mean diastolic ≥105 mm Hg), mean age 46.5 years.
I
Intervention
Propranolol 80 mg twice daily or metoprolol 100 mg twice daily, combined with exercise conditioning (40 sessions of aerobic exercise with heart rate monitoring over 10 weeks).
C
Comparator
Placebo combined with exercise conditioning (40 sessions of aerobic exercise with heart rate monitoring over 10 weeks).
O
Outcome
Exercise tolerance, exercise conditioning response, and blood pressure response to conditioning.surrogate

In hypertensive patients undergoing an aerobic exercise program, beta-1-selective blockers (metoprolol) preserve blood-pressure-lowering effects and affect exercise capacity less than nonselective blockers (propranolol).

Abstract

STUDY OBJECTIVE: To determine whether beta-adrenergic blocking agents affect exercise tolerance, exercise conditioning response, and blood pressure response to conditioning in hypertensive patients. DESIGN: Randomized, double-blinded, placebo-controlled trial with a 10-week exercise period. SETTING: Outpatient, monitored exercise program at a community-based, university-sponsored cardiac rehabilitation facility. PATIENTS: Thirty adults with mean resting blood pressure of 145 mm Hg or greater (systolic), 95 mm Hg or greater (diastolic), or a combined systolic and diastolic pressure of 140/90 mm Hg or greater. Mean systolic pressure of 170 mm Hg or more or mean diastolic pressure of 105 mm Hg or more was exclusionary. Mean blood pressure was 145/95 mm Hg; mean age was 46.5 years. INTERVENTION: The beta-1-nonselective blocker was propranolol, 80 mg twice daily. The beta-1-selective blocker was metoprolol, 100 mg twice daily, compared with placebo. All patients did exercise conditioning consisting of 40 sessions of aerobic exercise with heart rate monitoring. MEASUREMENTS AND MAIN RESULTS: Resting systolic blood pressure measured without drug therapy was lowered markedly after exercise conditioning on placebo (146 to 135 mm Hg) and on metoprolol (144 to 133 mm Hg) (P less than 0.05), but not on propranolol (no change). Acutely, propranolol decreased both maximal oxygen consumption (VO2max) and exercise duration compared with metoprolol and placebo. Chronically, VO2max increased 24% (95% CI, 8 to 40) in response to training on placebo and 8% on metoprolol (95% CI, 3 to 14); it did not increase on propranolol (95% CI, -10 to 15). CONCLUSIONS: If an exercise program is to be recommended as an adjunct to pharmacologic beta-blockade for hypertension, blood-pressure-lowering effects are preserved and exercise capacity is less affected with a beta-1-selective agent than with a beta-1-nonselective agent. Antihypertensive medications may be avoided altogether for selected patients who sustain an aerobic exercise program.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Philip A. Ades (1988) studied this question.

synapsesocial.com/papers/6a993355555fc9bb84749f4ahttps://doi.org/10.7326/0003-4819-109-8-629
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Attenuation of exercise conditioning by beta-adrenergic blockade.1982 · 100 citations
  2. 2Physical Training Program in Arterial Hypertension2008 · 103 citations
  3. 3β‐Adrenoceptor blockers and the blood‐brain barrier1981 · 227 citations
  4. 4Conditioning Effects of Chronic Infusions of Dobutamine1979 · 58 citations
  5. 5The 1984 Report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure1984 · 602 citations